InvestorsHub Logo
Followers 11
Posts 748
Boards Moderated 0
Alias Born 01/28/2014

Re: None

Wednesday, 12/16/2020 9:43:09 AM

Wednesday, December 16, 2020 9:43:09 AM

Post# of 9396
No mind med patent? Article. Google it
New compound related to psychedelic ibogaine could treat addiction, depression
Date:
December 9, 2020
Source:
University of California - Davis
Summary:
A non-hallucinogenic version of the psychedelic drug ibogaine, with potential for treating addiction, depression and other psychiatric disorders, has been developed by researchers.
Share:

FULL STORY
A non-hallucinogenic version of the psychedelic drug ibogaine, with potential for treating addiction, depression and other psychiatric disorders, has been developed by researchers at the University of California, Davis. A paper describing the work is published Dec. 9 in Nature.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent MNMD News